DOUBLE-BOND REQUIREMENT FOR 5-LIPOXYGENASE PATHWAY

被引：0
作者：
WEI, YF
EVANS, RW
MORRISON, AR
SPRECHER, H
JAKSCHIK, BA
机构：
[1] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
[2] OHIO STATE UNIV,COLUMBUS,OH 43210
来源：
FEDERATION PROCEEDINGS | 1984年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：932 / 932
页数：1
相关论文
共 50 条
[31]   ARACHIDONATE 5-LIPOXYGENASE [J].
RADMARK, O .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (2-3) :171-184
[32]   INHIBITORS OF 5-LIPOXYGENASE [J].
BROOKS, DW ;
SUMMERS, JB ;
KERDESKY, FAJ ;
HOLMS, JH ;
MAZDIYASNI, H ;
RATAJCZYK, JD ;
DYER, RD ;
CARTER, GW .
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1987, 64 (05) :668-668
[33]   The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease [J].
Poeckel, Daniel ;
Funk, Colin D. .
CARDIOVASCULAR RESEARCH, 2010, 86 (02) :243-253
[34]   INFLUENCE OF HYPOXIA ON 5-LIPOXYGENASE PATHWAY IN RAT ALVEOLAR MACROPHAGES [J].
OHWADA, A ;
KIRA, S ;
YAMASHITA, T .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 39 (01) :69-73
[35]   Interfering with the 5-lipoxygenase pathway as a novel way to treat asthma [J].
Drazen, JM .
ASTHMA AND ALLERGIC DISEASES: PHYSIOLOGY, IMMUNOPHARMACOLOGY, AND TREATMENT, 1998, :357-364
[36]   5-lipoxygenase inhibitors [J].
不详 .
DRUG DISCOVERY TODAY, 1997, 2 (06) :248-249
[37]   Leukotriene Production by the 5-lipoxygenase Pathway is Linked to Microvascular Dysfunction [J].
Wikstrom, Johannes ;
Karlsson, Daniel ;
Behrendt, Margareta ;
Swedlund, Sara ;
Westergren, Helena ;
Hovdal, Daniel ;
Sundquist, Monika ;
Andreasson, Anne-Christine ;
Jonsson-Rylander, Ann-Cathrine ;
Mansson, Marianne ;
Whatling, Carl ;
Gan, Li-ming .
CIRCULATION, 2016, 134
[38]   CLINICAL-STUDIES WITH AGENTS ACTIVE ON THE 5-LIPOXYGENASE PATHWAY [J].
DRAZEN, J .
ALLERGY, 1995, 50 (22) :22-26
[39]   EXAMINATION OF THE 5-LIPOXYGENASE/LEUKOTRIENE PATHWAY IN ADVANCED ATHEROSCLEROTIC LESION AND ABDOMINAL AORTIC ANEURYSM DEVELOPMENT IN 5-LIPOXYGENASE/APOE DEFICIENT MICE [J].
Cao, R. Y. ;
Funk, C. D. .
ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) :1-1
[40]   EPOXIDATION OF STILBENE DOUBLE-BOND, A MAJOR PATHWAY IN AMINOSTILBENE METABOLISM [J].
METZLER, M ;
NEUMANN, HG .
XENOBIOTICA, 1977, 7 (03) :117-132
12345